immunity News and Research

RSS

Birdflu vaccine successful on monkeys

A bird flu vaccine for humans could be only months away since the success of a vaccine on monkeys in Vietnam, researchers hope to have a vaccine ready for testing in humans later this year.

10 Mar 2005

Vietnamese relatives have birdflu but they're not sick

The H5N1 virus has killed 34 Vietnamese, 12 Thais and a Cambodian since it swept across large parts of Asia at the end of 2003. Two elderly Vietnamese, related to family who died of bird flu have tested positive for the deadly virus despite showing no symptoms.

9 Mar 2005

Vietnam finds bird flu vaccine

Vietnam, hard hit by an epidemic that has killed 47 people in Asia and wiped out many millions of poultry has successfully tested a birdflu vaccine on monkeys and tests in humans could be only months away.

7 Mar 2005

Important advance in our understanding of colorectal cancer

An international team of medical scientists has made an important advance in our understanding of the second most fatal form of cancer in the industrialized world. Professor Jeremy R. Jass, who holds a Canada Research Chair in Gastrointestinal Pathology at McGill University in Montreal

3 Mar 2005

UK Government stockpiles anti-viral medicine Tamiflu from Roche

In an attempt to prevent the spread of the influenza pandemic birdflu the U.K. government will buy 200 million pounds ($384 million) worth of the anti-viral medicine Tamiflu from Roche, one of Switzerland's largest drug companies. The influenza pandemic could kill more than 50,000 people in the country.

1 Mar 2005

alpha-defensin-1, a protein found in immune cells, can control HIV infection

Theresa Chang and colleagues at Mount Sinai School of Medicine analyzed how alpha-defensin-1 inhibits HIV infection in white blood cells (CD4+ T cells). Defensins have been shown to have anti-HIV activity. The body attempts to protect itself from HIV infection via the innate immune system.

1 Mar 2005

Scientists re-produce the human body's own cancer-killing cells through gene therapy

New hope to cancer sufferers comes from research by South Korean scientists who have found a way to re- produce the human body's own cancer-killing cells through gene therapy.

1 Mar 2005

OPAL, major discovery in the fight against AIDS

Australian researchers have made a major discovery in the fight against AIDS, with the development of a novel, simple and safe technique for boosting the body’s immune response to deadly viruses like HIV, which is even effective against drug resistant forms of the disease.

1 Mar 2005

VIRxSYS novel HIV gene therapy yields exciting results

VIRxSYS Corporation reports unexpected and unprecedented findings in its ongoing Phase I clinical trial of its VRX496 therapy in patients with HIV.

28 Feb 2005

Scientists identify immune-system mutation

A team of Fox Chase Cancer Center scientists led by immunologist Dietmar J. Kappes, Ph.D., has identified the genetic mutation that keeps a mouse strain from developing white blood cells, or lymphocytes, called helper T cells. The report by Kappes and his colleagues appears in the Feb. 24 issue of Nature.

27 Feb 2005

Herpesviruses are everywhere!

A population-based study of primary human herpesvirus 6 infection is reported in the current issue of the The New England Journal of Medicine (NEJM).

24 Feb 2005

New information that may help guide design of vaccines for HIV-1

Scientists have uncovered new information that may help guide design of vaccines for HIV-1, the virus that causes AIDS. A new detailed structural analysis of the complex formed by an anti-HIV antibody called 4E10 and its specific target provides insight into why this particular antibody is so broadly effective, a rare characteristic for HIV discovered thus far.

22 Feb 2005

Antibody that neutralizes most HIV strains

A group of scientists from The Scripps Research Institute and several other institutions has solved the structure of a rare human antibody that broadly neutralizes human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome (AIDS).

22 Feb 2005

Abandoned bones suggest TB wiped out leprosy in battle of killer diseases

The spread of tuberculosis may have killed off leprosy in Europe in the Middle Ages, according to research published in the latest issue of the Royal Society Proceedings B.

8 Feb 2005

Research confirms how early-life events shape later physiology

Underscoring the value of good prenatal care, new research suggests that early infection may create a cognitive vulnerability that appears later during stress on the immune system.

8 Feb 2005

Malaria experts to unveil top-flight research during international conference

Some of the world’s leading authorities on tropical diseases and parasitic infections will gather for an international conference at The University of Nottingham to discuss the latest breakthroughs in research and treatments.

3 Feb 2005

Solbec announces pre-clinical study to confirm findings into the effect of Coramsine combined with CpG in the treatment of murine mesothelioma

Solbec Pharmaceuticals Ltd has announced the commencement of a pre-clinical study to confirm and extend the findings of an earlier investigation into the effect of Coramsine™ combined with CpG in the treatment of murine mesothelioma.

3 Feb 2005

Bacterial spread all down to chance: some strains 'just the luckyones'

Scientists have discovered that factors such as human immunity and drug resistance are less important to the success of bacterial spread than previously thought.

3 Feb 2005

Research may provide the basis for development of a new, extensive immunotherapy for human tumors

Scientists have made significant progress towards understanding how the immune system can be more specifically and efficiently targeted against cancer cells. The research, published in the January issue of Immunity, may provide the basis for development of a new, extensive immunotherapy for human tumors.

26 Jan 2005

School influenza vaccinations best strategy for slowing flu transmission

The best strategy for minimizing future influenza morbidity and mortality would be to concentrate vaccinations in school children and high-risk groups, according to a new research commentary by scientists at Emory University.

25 Jan 2005